Demis Hassabis
Demis Hassabis is the co-founder and CEO of Google DeepMind, the AI research organization behind systems including AlphaGo and AlphaFold. He is a Nobel Prize-winning AI researcher and public representative for Google DeepMind’s frontier AI work.
Hassabis Says AI Drug Discovery Could Transform Medicine Within 20 Years
Demis Hassabis told Two Minute Papers’ Károly Zsolnai-Fehér that AI could help produce cures for most diseases on a 10- to 20-year horizon, but he framed the claim as a platform problem rather than a countdown. The DeepMind chief argued that AlphaFold is only one component of a broader drug-discovery system, with Isomorphic Labs and DeepMind building multiple specialized models to predict biological behavior, design molecules and eventually accelerate validation. He stressed that clinical testing and regulatory trust remain separate bottlenecks, and that evidence from working AI-designed drugs would have to come before any process change.
Google’s AI Strategy Emphasizes Scale Over Frontier Model Leadership
Kevin Roose and Casey Newton read Google’s I/O announcements as evidence of a company that has regained operational confidence in AI without yet proving frontier leadership. Roose argues Google is leaning on speed, cost, distribution and infrastructure — putting capable models across search, coding, video and cloud tools at enormous scale. Newton is more skeptical: fast and cheap, he says, is not the same as best, and many of Google’s most important product claims remain untested until users can rely on them in real workflows.